Loading clinical trials...
Loading clinical trials...
A Study to evaluate the utility of the ProLung China Test as an adjunct to CT scan in the diagnosis of lung cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Chinese Alliance Against Lung Cancer
NCT02448225 · Lung Carcinoma, Solitary Pulmonary Nodule, and more
NCT02983903 · Solitary Pulmonary Nodule, Multiple Pulmonary Nodules
NCT04192201 · Multiple Pulmonary Nodules
NCT03795181 · Multiple Pulmonary Nodules
NCT01465425 · Solitary Pulmonary Nodules, Multiple Pulmonary Nodules, and more
Nantong Tumor Hospital
Nantong, Jiangsu
Shanghai Dongfang Hospital of Tongji University
Shanghai, Shanghai Municipality
Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions